Cargando…

Incidence of invasive Group B Streptococcal infection and the risk of infant death and cerebral palsy: a Norwegian Cohort Study

BACKGROUND: Group B Streptococcus (GBS) is the leading cause of invasive neonatal infection worldwide. In high-income countries mortality rates are 4–10%, and among survivors of GBS meningitis 30–50% have neurodevelopmental impairments. We hypothesized that invasive GBS infection was associated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Mynarek, Maren, Bjellmo, Solveig, Lydersen, Stian, Afset, Jan E., Andersen, Guro L., Vik, Torstein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660635/
https://www.ncbi.nlm.nih.gov/pubmed/32726797
http://dx.doi.org/10.1038/s41390-020-1092-2
_version_ 1784613229474873344
author Mynarek, Maren
Bjellmo, Solveig
Lydersen, Stian
Afset, Jan E.
Andersen, Guro L.
Vik, Torstein
author_facet Mynarek, Maren
Bjellmo, Solveig
Lydersen, Stian
Afset, Jan E.
Andersen, Guro L.
Vik, Torstein
author_sort Mynarek, Maren
collection PubMed
description BACKGROUND: Group B Streptococcus (GBS) is the leading cause of invasive neonatal infection worldwide. In high-income countries mortality rates are 4–10%, and among survivors of GBS meningitis 30–50% have neurodevelopmental impairments. We hypothesized that invasive GBS infection was associated with increased risk of infant mortality and cerebral palsy (CP). METHODS: All children born alive in Norway during 1996–2012 were included. Data were collected from three national registers. Invasive GBS infection during infancy was categorized into early-onset disease (EOD), late-onset disease (LOD), and very late-onset disease (VLOD). Primary outcomes were infant mortality and CP. RESULTS: Invasive GBS infection was diagnosed in 625 children (incidence: 0.62 per 1000 live births; 95% confidence interval (CI): 0.57–0.67). The incidence of EOD was 0.41 (0.37–0.45), of LOD 0.20 (0.17–0.23), and of VLOD 0.012 (0.007–0.021). The annual incidence of LOD increased slightly. Among infected infants, 44 (7%) died (odds ratio (OR): 24.5; 95% CI: 18.0–33.3 compared with the background population). Among survivors, 24 (4.1%) children were later diagnosed with CP, compared with 1887 (0.19%) in the background population (OR: 22.9; 95% CI: 15.1–34.5). CONCLUSION: Despite a relatively low incidence of invasive GBS infection in Norway, the risk of death and CP remains high. Improvements in prevention strategies are needed. IMPACT: During the first decade of the twenty-first century, invasive GBS disease in infancy is still associated with high mortality. Despite the overall low incidence of invasive GBS disease, the incidence of LOD increased during the study period. The finding that invasive GBS infection in the neonatal period or during infancy is associated with an excess risk of CP, comparable to the risk following moderate preterm birth and moderate low Apgar scores, adds to the existing literature. The results of this study emphasize the importance of adhering to guidelines and the need for better prevention strategies.
format Online
Article
Text
id pubmed-8660635
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group US
record_format MEDLINE/PubMed
spelling pubmed-86606352021-12-27 Incidence of invasive Group B Streptococcal infection and the risk of infant death and cerebral palsy: a Norwegian Cohort Study Mynarek, Maren Bjellmo, Solveig Lydersen, Stian Afset, Jan E. Andersen, Guro L. Vik, Torstein Pediatr Res Population Study Article BACKGROUND: Group B Streptococcus (GBS) is the leading cause of invasive neonatal infection worldwide. In high-income countries mortality rates are 4–10%, and among survivors of GBS meningitis 30–50% have neurodevelopmental impairments. We hypothesized that invasive GBS infection was associated with increased risk of infant mortality and cerebral palsy (CP). METHODS: All children born alive in Norway during 1996–2012 were included. Data were collected from three national registers. Invasive GBS infection during infancy was categorized into early-onset disease (EOD), late-onset disease (LOD), and very late-onset disease (VLOD). Primary outcomes were infant mortality and CP. RESULTS: Invasive GBS infection was diagnosed in 625 children (incidence: 0.62 per 1000 live births; 95% confidence interval (CI): 0.57–0.67). The incidence of EOD was 0.41 (0.37–0.45), of LOD 0.20 (0.17–0.23), and of VLOD 0.012 (0.007–0.021). The annual incidence of LOD increased slightly. Among infected infants, 44 (7%) died (odds ratio (OR): 24.5; 95% CI: 18.0–33.3 compared with the background population). Among survivors, 24 (4.1%) children were later diagnosed with CP, compared with 1887 (0.19%) in the background population (OR: 22.9; 95% CI: 15.1–34.5). CONCLUSION: Despite a relatively low incidence of invasive GBS infection in Norway, the risk of death and CP remains high. Improvements in prevention strategies are needed. IMPACT: During the first decade of the twenty-first century, invasive GBS disease in infancy is still associated with high mortality. Despite the overall low incidence of invasive GBS disease, the incidence of LOD increased during the study period. The finding that invasive GBS infection in the neonatal period or during infancy is associated with an excess risk of CP, comparable to the risk following moderate preterm birth and moderate low Apgar scores, adds to the existing literature. The results of this study emphasize the importance of adhering to guidelines and the need for better prevention strategies. Nature Publishing Group US 2020-07-29 2021 /pmc/articles/PMC8660635/ /pubmed/32726797 http://dx.doi.org/10.1038/s41390-020-1092-2 Text en © The Author(s) 2020, corrected publication 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Population Study Article
Mynarek, Maren
Bjellmo, Solveig
Lydersen, Stian
Afset, Jan E.
Andersen, Guro L.
Vik, Torstein
Incidence of invasive Group B Streptococcal infection and the risk of infant death and cerebral palsy: a Norwegian Cohort Study
title Incidence of invasive Group B Streptococcal infection and the risk of infant death and cerebral palsy: a Norwegian Cohort Study
title_full Incidence of invasive Group B Streptococcal infection and the risk of infant death and cerebral palsy: a Norwegian Cohort Study
title_fullStr Incidence of invasive Group B Streptococcal infection and the risk of infant death and cerebral palsy: a Norwegian Cohort Study
title_full_unstemmed Incidence of invasive Group B Streptococcal infection and the risk of infant death and cerebral palsy: a Norwegian Cohort Study
title_short Incidence of invasive Group B Streptococcal infection and the risk of infant death and cerebral palsy: a Norwegian Cohort Study
title_sort incidence of invasive group b streptococcal infection and the risk of infant death and cerebral palsy: a norwegian cohort study
topic Population Study Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660635/
https://www.ncbi.nlm.nih.gov/pubmed/32726797
http://dx.doi.org/10.1038/s41390-020-1092-2
work_keys_str_mv AT mynarekmaren incidenceofinvasivegroupbstreptococcalinfectionandtheriskofinfantdeathandcerebralpalsyanorwegiancohortstudy
AT bjellmosolveig incidenceofinvasivegroupbstreptococcalinfectionandtheriskofinfantdeathandcerebralpalsyanorwegiancohortstudy
AT lydersenstian incidenceofinvasivegroupbstreptococcalinfectionandtheriskofinfantdeathandcerebralpalsyanorwegiancohortstudy
AT afsetjane incidenceofinvasivegroupbstreptococcalinfectionandtheriskofinfantdeathandcerebralpalsyanorwegiancohortstudy
AT andersengurol incidenceofinvasivegroupbstreptococcalinfectionandtheriskofinfantdeathandcerebralpalsyanorwegiancohortstudy
AT viktorstein incidenceofinvasivegroupbstreptococcalinfectionandtheriskofinfantdeathandcerebralpalsyanorwegiancohortstudy